1Y Close · As of Aug 26, 2026
Tego Science operates in the Pharmaceuticals sector.
Legal name: Tego Science, Inc.
In fiscal year 2025, Tego Science (191420) reported revenue of 5.9 billion KRW, down 12.1% from 6.8 billion KRW a year earlier.
Operating profit was -4.4 billion KRW and net income was -7.0 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 61.5 billion KRW, with a P/B of 1.22.
These figures can be verified in the DART filing (receipt no. 20260625000184).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 5.9B | -4.4B | -7.0B |
| 2024 | 6.8B | -2.2B | 3.3B |
| 2023 | 7.8B | -1.2B | -2.3B |
Recent Filings
Officer/Major Shareholder Trading Plan Report
Semi-Annual Report (2026.06)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-18 | Officer/Major Shareholder Trading Plan Report |
| 2026-08-14 | Semi-Annual Report (2026.06) |